BLIS Technologies (NZSE:BLT) EBIT per Share: NZ$0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BLIS Technologies EBIT per Share?

BLIS Technologies NZSE:BLT -5.88% EBIT per Share is NZ$0.00 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 1,173 Biotechnology companies, BLIS Technologies ranks better than 57.03% on this metric.

BLIS Technologies's EBIT per Share for the six months ended in Mar. 2026 was NZ$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.00.

During the past 3 years, the average EBIT per Share Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BLIS Technologies's EBIT per Share or its related term are showing as below:

NZSE:BLT' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.7   Med: 22.35   Max: 45
Current: 20.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BLIS Technologies was 45.00% per year. The lowest was -19.70% per year. And the median was 22.35% per year.

NZSE:BLT's 3-Year EBIT Growth Rate is ranked better than
57.03% of 1173 companies
in the Biotechnology industry
Industry Median: 15.5 vs NZSE:BLT: 20.60

BLIS Technologies's EBIT for the six months ended in Mar. 2026 was NZ$0.33 Mil.

BLIS Technologies  (NZSE:BLT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BLIS Technologies EBIT per Share Related Terms

BLIS Technologies EBIT per Share Historical Data

* Premium members only.

The historical data trend for BLIS Technologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BLIS Technologies EBIT per Share Chart

BLIS Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 0.00

BLIS Technologies Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BLIS Technologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BLIS Technologies's EBIT per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBIT per Share(A: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=0.792/1279.302
=0.00

BLIS Technologies's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=0.325/1279.302
=0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of NZ$0.00 mean?
BLIS Technologies (NZSE:BLT) has a EBIT per Share of NZ$0.00 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BLIS Technologies and its competitors. According to the industry distribution chart, BLIS Technologies ranks #504 out of 1173 companies in the Biotechnology industry, placing it in the top 43%.
Is BLIS Technologies' EBIT per Share too high?
BLIS Technologies' current EBIT per Share is NZ$0.00. Based on the distribution chart, BLIS Technologies ranks #504 out of 1173 companies in the Biotechnology industry, which is above the industry midpoint.
How does BLIS Technologies' EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #504 out of 1173 companies for EBIT per Share. This puts BLIS Technologies in the upper half of its industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BLIS Technologies and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BLIS Technologies's current EBIT per Share is NZ$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 20% below its estimated fair value. The current EBIT per Share is NZ$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current EBIT per Share is NZ$0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BLIS Technologies Business Description

Address 399 Moray Place, Dunedin Central, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.